|
|
|
Volumn 14, Issue 7, 2001, Pages 61-69
|
|
Mild-to-moderate uncomplicated hypertension: further analysis of a cost-effectiveness study of five drugs.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
BENZIMIDAZOLE DERIVATIVE;
BENZOIC ACID DERIVATIVE;
BENZOTHIADIAZINE DERIVATIVE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
TELMISARTAN;
THIAZIDE DIURETIC AGENT;
ARTICLE;
COMPARATIVE STUDY;
COST BENEFIT ANALYSIS;
COST OF ILLNESS;
DECISION TREE;
DRUG COST;
ECONOMICS;
HEALTH INSURANCE;
HUMAN;
HYPERTENSION;
PUBLICATION;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
BENZIMIDAZOLES;
BENZOATES;
BENZOTHIADIAZINES;
CALCIUM CHANNEL BLOCKERS;
COST OF ILLNESS;
COST-BENEFIT ANALYSIS;
DECISION TREES;
DIURETICS;
DRUG COSTS;
FORMULARIES;
HUMANS;
HYPERTENSION;
MANAGED CARE PROGRAMS;
SODIUM CHLORIDE SYMPORTER INHIBITORS;
|
|
EID: 0035409642
PISSN: 10965645
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
